Mapping the study topics and characteristics of HIV pre-exposure prophylaxis research literature: a protocol for a scoping review.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
24 05 2019
Historique:
entrez: 27 5 2019
pubmed: 28 5 2019
medline: 22 4 2020
Statut: epublish

Résumé

The research literature addressing pre-exposure prophylaxis (PrEP) has increased considerably over the last decade. To better understand the research areas and explore research gaps, we will conduct a scoping review to map study topics and describe study characteristics and populations in publications focused on PrEP. The purpose of this protocol is to describe planned methods for the scoping review. We will implement a comprehensive systematic literature search to identify PrEP citations in the United States Centres for Disease Control and Prevention HIV/AIDS Prevention Research Synthesis Project database that is unique and extensively focuses on HIV/sexually transmitted infections/hepatitis. We will screen and include studies that are (1) focused on HIV PrEP, (2) primary research with human participants and (3) published in English. Two reviewers will independently abstract data on authors' names, study years, countries, population characteristics and design. To describe and summarise study topics, we will use 19 codes and five categories that were developed from a preliminary study. The five categories are The findings will be presented at HIV-related conferences and published in peer-review journals.

Identifiants

pubmed: 31129574
pii: bmjopen-2018-024212
doi: 10.1136/bmjopen-2018-024212
pmc: PMC6537968
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e024212

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin Infect Dis. 2015 Nov 15;61(10):1601-3
pubmed: 26334052
Work. 2010;35(3):399-404
pubmed: 20364059
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):200-6
pubmed: 26761520
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
N Engl J Med. 2015 Dec 3;373(23):2237-46
pubmed: 26624850
JAMA Intern Med. 2016 Jan;176(1):75-84
pubmed: 26571482

Auteurs

Emiko Kamitani (E)

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention Prevention Research Centers, Atlanta, Georgia, USA.

Adebukola H Johnson (AH)

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention Prevention Research Centers, Atlanta, Georgia, USA.
ICF International Inc, Fairfax, Virginia, USA.

Megan Wichser (M)

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention Prevention Research Centers, Atlanta, Georgia, USA.
ICF International Inc, Fairfax, Virginia, USA.

Yuko Mizuno (Y)

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention Prevention Research Centers, Atlanta, Georgia, USA.

Julia B DeLuca (JB)

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention Prevention Research Centers, Atlanta, Georgia, USA.

Darrel H Higa (DH)

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention Prevention Research Centers, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH